Use of Analgesics and Pain Scores After Pediatric Adenotonsillectomy
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of the study is to quantify the use of pain medications given to children aged 3 - 12 years as well as their pain level through pain scores after they have undergone a tonsillectomy or adenotonsillectomy surgery at Doernbecher Children's Hospital (DCH). We would like to learn more about the pain medications given and the pain scores of children post-surgery for the first 5 days following discharge from the hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 14, 2020
CompletedFirst Posted
Study publicly available on registry
April 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedApril 16, 2020
April 1, 2020
1.3 years
April 14, 2020
April 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total opioid administered during POD 1-5 (converted to morphine dose equivalents)
Total amount of opioid analgesics administered at home on Post-operative days 1-5.
POD 1-5
Secondary Outcomes (7)
Mean Worst Pain Scores POD 1-5
POD 1-5
Total acetaminophen administered on POD 1-5
POD 1-5
Total ibuprofen administered on POD 1-5
POD 1-5
Frequency of Vomiting on POD 1-5
POD 1-5
Duration of impaired drinking
POD 1-5
- +2 more secondary outcomes
Study Arms (1)
Pediatric tonsillectomy patients
All patients enrolled into study prior to undergoing tonsillectomy or adenotonsillectomy
Interventions
Parents will complete medication tracking form for 5 days after child's surgery. They will track medications administered, pain scores, nausea and vomiting
Eligibility Criteria
1. Parent or guardian refusal of consent 2. Child has severe OSA (Apnea-Hypopnea Index (AHI) ≥10 or O2 Saturation \<85% on polysomnogram) 3. Child with behavioral disorders (ADHD, ASD, etc.) 4. Child with genetic disorders (down syndrome, mucopolysaccharidoses, achondroplasia, Prader-Willi syndrome, etc.) 5. Child with neuromuscular disorders (muscular dystrophy, hypotonia, etc.) 6. Child with a history of extremely preterm (born at \<28 weeks) or very preterm (born at 28-32 weeks) 7. Child with moderate to severe developmental delay 8. Child is obese (BMI ≥ 95th percentile) 9. Child with craniofacial anomalies (retrognathia, micrognathia, midface hypoplasia) 10. Child with allergies to acetaminophen, ibuprofen, morphine, fentanyl or oxycodone
You may qualify if:
- Child aged 3-12 that is scheduled to undergo tonsillectomy or adenotonsillectomy, with or without ear tubes or Parent or guardian of a child aged 3-12 years old that is scheduled to undergo tonsillectomy or adenotonsillectomy, with or without ear tubes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health & Science University (OHSU)
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 14, 2020
First Posted
April 16, 2020
Study Start
August 1, 2019
Primary Completion
December 1, 2020
Study Completion
June 1, 2021
Last Updated
April 16, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share